Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Russian researchers develop tool to accelerate discovery of new antibiotics
9+ hour, 55+ min ago (206+ words) Researchers from Skolkovo Institute of Science and Technology, a partner of TV BRICS, and other Russian scientific centres have developed an advanced reporter system to accelerate the discovery of new antibiotics. The upgraded reporter system is designed to detect compounds…...
Overcoming Viral Vector Supply Bottlenecks and CMC Scalability for Advanced Biotherapeutics
15+ hour, 2+ min ago (964+ words) geneonline.com Overcoming Viral Vector Supply Bottlenecks and CMC Scalability for Advanced Biotherapeutics The Cell and Gene Therapy (CGT) session at BIO Asia-Taiwan 2026 brought together leading genetic medicine pioneers, vector bioprocessing engineers, and clinical investigators to evaluate the rapid evolution…...
A “Natural Ozempic” Discovered by AI?
1+ day, 5+ hour ago (1004+ words) Posted July 24, 2026 | Reviewed by Monica Vilhauer Ph.D. The success of drugs such as Ozempic and Wegovy has transformed how scientists think about obesity. These medications demonstrate that appetite and body weight are not simply products of willpower. They are regulated…...
Sprint Bioscience to use Lilly Tunelab in drug development
1+ day, 13+ hour ago (20+ words) BioWorld News Sprint Bioscience to use Lilly Tunelab in drug development...
Why Both Stimulating And Blocking GLP-1R Helps People Lose Weight
1+ day, 3+ hour ago (239+ words) Drugs such as such as Wegovy and Ozempic stimulate GLP-1R while others act on both it and the glucose-dependent insulinotropic polypeptide receptor (GIPR). Drugs like Mounjaro and Zepbound stimulate GIPR while those like MariTide (currently in phase 3 clinical trials) combine…...
Medidata Launches Medidata Plus AI Layer to Standardize Clinical Trial Data and Workflows
1+ day, 7+ hour ago (229+ words) How Medidata Plus Unifies Clinical R&D Across Global Portfolios The clinical research, biopharmaceutical R&D, and Contract Research Organization (CRO) sectors are facing an efficiency bottleneck. While 92% of life sciences decision-makers plan to increase AI investments, only 29% state that…...
VLP-mediated cytosolic delivery via receptor-triggered membrane fusion
1+ day, 11+ hour ago (185+ words) The figure details the structural components and delivery steps of an engineered virus-like particle (VLP). (Left) The VLP consists of a lipid bilayer envelope embedded with specific surface proteins and encapsulated cargo proteins. (Right) The delivery process involves the specific…...
OpenAI Researcher Miles Wang Departs to Launch AI Drug Discovery Startup
1+ day, 9+ hour ago (289+ words) Miles Wang, an OpenAI researcher known for work applying AI to scientific and biological discovery, is leaving the company to start a new venture focused on AI models for drug discovery, according to people familiar with his plans. Several other…...
Biointron Launches RushData, an Integrated Platform for AI-Driven Antibody Discovery with 1-Day CHO Expression
1+ day, 5+ hour ago (142+ words) Biointron Biological USA Inc. ("Biointron"), a leading contract research organization for antibody discovery, expression, and optimization, has launched RushData. RushData is an integrated service platform designed to support the growing demands of AI- and machine learning-driven antibody discovery for global…...